BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 15858200)

  • 1. The cost of institutional review boards in academic medical centers.
    Sugarman J; Getz K; Speckman JL; Byrne MM; Gerson J; Emanuel EJ;
    N Engl J Med; 2005 Apr; 352(17):1825-7. PubMed ID: 15858200
    [No Abstract]   [Full Text] [Related]  

  • 2. The costs of institutional review boards.
    Dickler HB; Korn D
    N Engl J Med; 2005 Jul; 353(3):315-7; author reply 315-7. PubMed ID: 16034023
    [No Abstract]   [Full Text] [Related]  

  • 3. Determining the costs of Institutional Review Boards.
    Speckman JL; Byrne MM; Gerson J; Getz K; Wangsmo G; Muse CT; Sugarman J;
    IRB; 2007; 29(2):7-13. PubMed ID: 17847609
    [No Abstract]   [Full Text] [Related]  

  • 4. Institutional review boards: the cost to academic medical centers.
    Hanauer SB
    Nat Clin Pract Gastroenterol Hepatol; 2005 Jul; 2(7):287. PubMed ID: 16265262
    [No Abstract]   [Full Text] [Related]  

  • 5. Financial relationships of institutional review board members.
    Miller FG
    N Engl J Med; 2007 Mar; 356(9):965; author reply 965. PubMed ID: 17329710
    [No Abstract]   [Full Text] [Related]  

  • 6. The costs of institutional review boards.
    Bhat S; Hegde TT
    N Engl J Med; 2005 Jul; 353(3):315-7; author reply 315-7. PubMed ID: 16038060
    [No Abstract]   [Full Text] [Related]  

  • 7. Costs and care in academic medical centers. Interview by Jane Stein.
    Heyssel RM
    Bus Health; 1987 Jan; 4(3):50-2. PubMed ID: 10280003
    [No Abstract]   [Full Text] [Related]  

  • 8. The public's perspective on academic medicine and clinical research.
    Stern AR
    Bull N Y Acad Med; 1981; 57(6):476-9. PubMed ID: 6941841
    [No Abstract]   [Full Text] [Related]  

  • 9. Establishing procedures for institutional oversight of stem cell research.
    Zettler P; Wolf LE; Lo B
    Acad Med; 2007 Jan; 82(1):6-10. PubMed ID: 17198282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Central institutional review board-facilitated review metrics omit critical components.
    Katz MS; Smith ML
    J Clin Oncol; 2010 Feb; 28(6):e105; author reply e106. PubMed ID: 20100953
    [No Abstract]   [Full Text] [Related]  

  • 11. Minimal-risk waiver of informed consent and exception from informed consent (Final Rule) studies at institutional review boards nationwide.
    Ernst AA; Weiss SJ; Nick TG; Iserson K; Biros MH
    Acad Emerg Med; 2005 Nov; 12(11):1134-7. PubMed ID: 16264084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medical research oversight from the corporate governance perspective: comparing institutional review boards and corporate boards.
    Saver RS
    William Mary Law Rev; 2004 Nov; 46(2):619-730. PubMed ID: 17167924
    [No Abstract]   [Full Text] [Related]  

  • 13. Institutional review boards and collaborations between academia and industry: some counterproductive policies and practices.
    Levine RJ
    Circulation; 1985 Aug; 72(2 Pt 2):I48-50. PubMed ID: 4006159
    [No Abstract]   [Full Text] [Related]  

  • 14. Academic health centers: privileged market players?
    Manag Care Interface; 1998 Jul; 11(7):56, 59. PubMed ID: 10181570
    [No Abstract]   [Full Text] [Related]  

  • 15. The cost of institutional review board procedures in multicenter observational research.
    Humphreys K; Trafton J; Wagner TH
    Ann Intern Med; 2003 Jul; 139(1):77. PubMed ID: 12834327
    [No Abstract]   [Full Text] [Related]  

  • 16. The problems and benefits of associating academic medical centers with health-maintenance organizations.
    Hoft RH; Glaser RJ
    N Engl J Med; 1982 Dec; 307(27):1681-9. PubMed ID: 7144867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The HIPAA privacy rule: practical advice for academic and research institutions.
    Gunter KP
    Healthc Financ Manage; 2002 Feb; 56(2):50-4. PubMed ID: 11842502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conflicts of interest in research: how IRBs address their own conflicts.
    Wolf LE; Zandecki J
    IRB; 2007; 29(1):6-12. PubMed ID: 17855838
    [No Abstract]   [Full Text] [Related]  

  • 19. Financial conflicts of interest in human subjects research: proposals for a more effective regulatory scheme.
    Jordan KA
    Wash Lee Law Rev; 2003; 60(1):15-109. PubMed ID: 16273696
    [No Abstract]   [Full Text] [Related]  

  • 20. Oversight of financial conflicts of interest in commercially sponsored research in academic and nonacademic settings.
    Weinfurt KP; Hall MA; Hardy NC; Friedman JY; Schulman KA; Sugarman J
    J Gen Intern Med; 2010 May; 25(5):460-4. PubMed ID: 20186498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.